Eli Lilly expects revenue of USD 58 billion to USD 61 billion in 2025, with market estimates at USD 58.72 billion
Eli Lilly expects revenue of USD 58 billion to USD 61 billion in 2025, with market estimates at USD 58.72 billion. Risk warning and disclaimer: The market carries risks, and investments should be made cautiously. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk
Eli Lilly expects revenue of USD 58 billion to USD 61 billion in 2025, with market estimates at USD 58.72 billion.
Risk Warning and Disclaimer
The market has risks, and investment requires caution. This article does not constitute personal investment advice and does not take into account the specific investment goals, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk